Business Context and Reporting Period
Company: ESCO Technologies Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 15, 2026
Event: Entry into a Material Definitive Agreement for the proposed acquisition of Megger Group Limited.
Key Financial Metrics and Transaction Details
This filing details a proposed acquisition rather than periodic financial results. Key transaction metrics include:
- Total Purchase Price: Approximately $2.35 billion.
- Consideration Structure:
- Cash: $922 million.
- Equity: 5.10 million shares of ESCO Technologies Inc. common stock (Consideration Shares).
- Adjustments: Subject to post-closing adjustments based on net debt and working capital of the target, payable in cash.
- Financing Arrangements:
- Best Efforts Facilities: Up to $1.5 billion aggregate principal (including a $500 million revolving credit facility and term loans).
- Backstop Facility: $500 million revolving facility and $100 million term loan A if primary financing is insufficient.
- Bridge Facility: Up to $975 million in 364-day bridge loans if term loan proceeds fall short.
Note: The filing does not provide current revenue, profit, cash flow, or margin data for ESCO Technologies Inc. or Megger Group Limited.
Material Changes and Conditions
The transaction is subject to several material conditions precedent, including:
- Expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
- Clearance from the Committee on Foreign Investment in the United States (CFIUS).
- Approvals from the Defense Counterintelligence and Security Agency.
- Other applicable foreign merger control and investment law approvals.
Termination Rights: If conditions are not satisfied by April 15, 2027 (subject to extensions), either party may terminate. ESCO may also terminate prior to closing if the Seller breaches fundamental warranties resulting in liability exceeding $100,000 or breaches pre-closing obligations causing material liability.
Outlook, Governance, and Risks
Shareholder Agreement Provisions:
- Board Representation: Seller (TBG AG) receives one board seat as long as it maintains at least 50% ownership of the Consideration Shares.
- Lock-up Period: 12-month restriction on transferring Consideration Shares, with 50% released after six months.
- Standstill: Seller Holders are limited to 24.5% beneficial ownership of ESCO common stock without Board consent after the Restricted Period.
- Consent Rights: Seller retains consent rights on fundamental business changes during the Restricted Period.
Risks and Contingencies:
- Failure to obtain regulatory approvals.
- Integration challenges and potential business disruption.
- Higher-than-expected operating costs or customer loss post-closing.
- Reliance on forward-looking statements which are not guarantees of future performance.
Investor Verification Checklist
- Verify the status of regulatory approvals (HSR, CFIUS, Defense Counterintelligence and Security Agency) required for closing.
- Confirm the final terms of the financing facilities (Best Efforts, Backstop, and Bridge) once executed.
- Review the full text of the Purchase Agreement (Exhibit 10.1) and Shareholder Agreement (Exhibit 10.2) for specific covenants and termination triggers.
- Assess the dilution impact of issuing 5.10 million new shares of common stock.
- Monitor the post-closing working capital and net debt adjustments which will affect the final cash consideration.